[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI954805A0 - Methods for using insulin-like growth factor binding proteins - Google Patents

Methods for using insulin-like growth factor binding proteins

Info

Publication number
FI954805A0
FI954805A0 FI954805A FI954805A FI954805A0 FI 954805 A0 FI954805 A0 FI 954805A0 FI 954805 A FI954805 A FI 954805A FI 954805 A FI954805 A FI 954805A FI 954805 A0 FI954805 A0 FI 954805A0
Authority
FI
Finland
Prior art keywords
insulin
methods
growth factor
binding proteins
factor binding
Prior art date
Application number
FI954805A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI954805A (en
Inventor
George N Cox
Deborah A Russell
Original Assignee
Amgen Boulder Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Boulder Inc filed Critical Amgen Boulder Inc
Publication of FI954805A0 publication Critical patent/FI954805A0/en
Publication of FI954805A publication Critical patent/FI954805A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743Insulin-like growth factor binding protein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI954805A 1993-04-07 1995-10-09 Methods for using insulin-like growth factor binding proteins FI954805A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4526593A 1993-04-07 1993-04-07
PCT/US1994/003755 WO1994022466A1 (en) 1993-04-07 1994-04-06 Methods of using insulin-like growth factor binding proteins

Publications (2)

Publication Number Publication Date
FI954805A0 true FI954805A0 (en) 1995-10-09
FI954805A FI954805A (en) 1995-11-15

Family

ID=21936902

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954805A FI954805A (en) 1993-04-07 1995-10-09 Methods for using insulin-like growth factor binding proteins

Country Status (7)

Country Link
EP (1) EP0708655A1 (en)
JP (1) JPH08508296A (en)
CN (1) CN1134111A (en)
AU (1) AU6626794A (en)
CA (1) CA2160154A1 (en)
FI (1) FI954805A (en)
WO (1) WO1994022466A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2601895A (en) * 1994-05-24 1995-12-18 Amgen Boulder Inc. Modified insulin-like growth factors
US7495087B2 (en) 1997-07-14 2009-02-24 Bolder Biotechnology, Inc. Cysteine muteins in the C-D loop of human interleukin-11
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US7153943B2 (en) 1997-07-14 2006-12-26 Bolder Biotechnology, Inc. Derivatives of growth hormone and related proteins, and methods of use thereof
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
JP2001510033A (en) 1997-07-14 2001-07-31 ボルダー バイオテクノロジー, インコーポレイテッド Derivatives of growth hormone and related proteins
AU6515499A (en) * 1998-10-16 2000-05-08 Musc Foundation For Research Development Fragments of insulin-like growth factor binding protein and insulin-like growth factor, and uses thereof
JP2002534119A (en) 1999-01-14 2002-10-15 ボルダー バイオテクノロジー, インコーポレイテッド Method for producing a protein having a free cysteine residue
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
WO2000050067A1 (en) * 1999-02-26 2000-08-31 Saltech I Göteborg Ab Method and composition for the regulation of hepatic and extrahepatic production of insulin-like growth factor-1
AUPR030900A0 (en) * 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex
EP1501866A4 (en) 2001-10-02 2006-02-08 Genentech Inc Apo-2 ligand variants and uses thereof
CA2489348A1 (en) 2002-06-24 2003-12-31 Genentech, Inc. Apo-2 ligand/trail variants and uses thereof
US7192738B2 (en) 2003-10-03 2007-03-20 Genentech, Inc. IGF binding proteins
WO2007041614A2 (en) 2005-10-03 2007-04-12 Bolder Biotechnology, Inc. Long acting vegf inhibitors and methods of use
EP2462945B1 (en) * 2006-08-16 2014-06-04 National Research Council of Canada Method of inhibiting angiogenesis, tumorigenesis and cathepsin activity
WO2015023596A1 (en) 2013-08-12 2015-02-19 Genentech, Inc. Compositions and method for treating complement-associated conditions
EP3137503A1 (en) 2014-05-01 2017-03-08 Genentech, Inc. Anti-factor d antibody variants and uses thereof
CN108472382A (en) 2015-10-30 2018-08-31 豪夫迈·罗氏有限公司 Anti- factor D antibody variants conjugate and application thereof
CN108289951A (en) 2015-10-30 2018-07-17 豪夫迈·罗氏有限公司 Anti- factor D antibody and conjugate
EP3534932B1 (en) * 2016-11-01 2024-05-22 Virginia Commonwealth University Treatment of diseases related to igfb3 and its receptor
CR20220489A (en) 2020-03-24 2022-10-31 Genentech Inc Tie2-binding agents and methods of use
CN116144667B (en) * 2022-12-29 2024-03-12 海南大学 Egg-shaped pompano insulin-like growth factor binding protein 1 gene, protein and application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK131988A (en) * 1988-03-11 1989-09-12 Erasmus University IGF BINDING PROTEIN, DNA STRUCTURE CODING FOR IGF BINDING PROTEIN AND VECTOR CONTAINING THIS DNA STRUCTURE
ATE132164T1 (en) * 1988-04-12 1996-01-15 Amgen Boulder Inc METHOD FOR INCREASE AND INHIBITING THE EFFECT OF AN INSULIN-LIKE GROWTH FACTOR
GB8826451D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Improvements in/relating to organic compounds
WO1992016221A1 (en) * 1991-03-15 1992-10-01 Synergen, Inc. Pegylation of polypeptides

Also Published As

Publication number Publication date
AU6626794A (en) 1994-10-24
EP0708655A1 (en) 1996-05-01
FI954805A (en) 1995-11-15
CA2160154A1 (en) 1994-10-13
WO1994022466A1 (en) 1994-10-13
JPH08508296A (en) 1996-09-03
CN1134111A (en) 1996-10-23

Similar Documents

Publication Publication Date Title
FI954805A (en) Methods for using insulin-like growth factor binding proteins
FI973543A (en) Method for preparing heteromultimeric polypeptides
DE69410636D1 (en) BINDING
IL107742A0 (en) Chemically-modified binding proteins
FI961071A0 (en) Method for preparing zeolite
AU5283793A (en) Recombinant specific binding protein
AU2866695A (en) E6 binding proteins
DE69413830D1 (en) METHOD FOR SULFONING OLEFINS WITH INTERNAL DOUBLE BINDING
DK132892D0 (en) PROTEINS
ZA975202B (en) Plants proteins
EP0796321A4 (en) E2 binding proteins
DE69423487D1 (en) FACILITIES FOR AQUACULTURE
GB9314802D0 (en) Modified proteins
DE59709984D1 (en) METHOD FOR WATERING COMPONENTS
EP0546081A4 (en) New insulin-like growth factor binding protein (igfbp-4)
AU3640397A (en) Ob protein binding protein
HU9400526D0 (en) Anti-microbial proteins
IL115317A0 (en) Proteins
TR199701666A3 (en) Proteins
GB9413316D0 (en) Novel proteins
DE69223434D1 (en) Calmodulin binding protein
DE59711552D1 (en) METHOD FOR WATERING COMPONENTS
IT1248875B (en) METHOD FOR BINDING BOOKS
SE9202720D0 (en) FIBRINOGEN BINDING PROTEIN
GB9313070D0 (en) Binding protein

Legal Events

Date Code Title Description
FD Application lapsed